Sanket Koul

Hospital chain Fortis Healthcare has signed an O&M agreement with Dion Group to operate a 300-bed hospital in Cuttack, marking its entry into Odisha and expanding its eastern India presence

While expanded traceability aims to curb counterfeit medicines, industry says predictive manufacturing could help reduce NSQ drugs

Industry says amendments reduce procedural burden while tightening documentation and record-keeping norms for drug manufacturers under the pricing order

The Gurugram-based developer will invest Rs 7,200 crore in construction and Rs 2,500 crore in land acquisition as it expands its project pipeline and branded housing portfolio

Development becomes fourth hotel to be launched under the partnership

Residential sales across the top seven cities fell to 90,715 units in Q2 2026, while new launches rose 7 per cent as developers continued to add inventory despite uncertainty

The drug regulator has directed manufacturers and distributors to supply IVF media and reagents only to registered ART clinics, strengthening oversight of assisted reproductive technologies

Ola Electric Technologies and ANI Technologies have renewed separate leases for 430,000 sq ft at Bengaluru's Prestige RMZ Star Tech campus with a combined rental of Rs 281.11 crore

Draft amendments to the Medical Device Rules seek to reduce manufacturing licence timelines for Class B, C and D devices to improve regulatory efficiency and ease of doing business

Draft amendments propose a 12-month minimum residual shelf life for imported drugs and an acknowledgement-based mechanism for importing medicines for research

WHO has sought additional information after reports linked suspected fake oxytocin injections to maternal deaths in Rajasthan, while the Centre cancelled the firm's licences

The US drugmaker has launched Tanstrive, a RET-targeted oral therapy for advanced or metastatic solid tumours, following marketing authorisation from the CDSCO

Hero MotoCorp and WeWork have signed separate long-term office leases at Bharti Real Estate's Worldmark complex in Aerocity, with a combined rental outlay of about Rs 922 crore

The Health Ministry will expand mandatory QR code-based traceability to vaccines, antimicrobials, anti-cancer, narcotic and psychotropic drugs in a phased rollout

The drug pricing regulator has directed manufacturers to regularly furnish production and sales data for scheduled formulations to strengthen monitoring of essential medicines

The 220-key luxury hotel on the Jaipur-Ajmer Highway is part of Manglam Group's broader Rs 1,000 crore hospitality investment plan over five years

Share of national developers in Delhi-NCR's residential supply has risen from 3 per cent in 2022 to over 13 per cent, driven by premium housing demand and infrastructure growth

Centre mandates periodic renewal of registrations for ART and surrogacy clinics to strengthen oversight, improve compliance, and boost patient confidence

The company has also deposited Rs 29.5 crore as security, with the lease including a 4.25 per cent rent escalation every year

Department of Pharmaceuticals invites stakeholder comments on proposed additions and deletions to the list of medical devices exempted from Global Trade Enquiry requirements